Candel Therapeutics, Inc.CADLNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P48
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | -3.24% |
| Q3 2025 | -15.13% |
| Q2 2025 | -3.19% |
| Q1 2025 | -48.19% |
| Q4 2024 | 11.55% |
| Q3 2024 | -6.05% |
| Q2 2024 | 26.55% |
| Q1 2024 | -13.69% |
| Q4 2023 | 15.74% |
| Q3 2023 | -22.42% |
| Q2 2023 | 33.50% |
| Q1 2023 | -57.14% |
| Q4 2022 | 26.63% |
| Q3 2022 | -32.22% |
| Q2 2022 | 11.87% |
| Q1 2022 | -53.74% |
| Q4 2021 | 24.02% |
| Q3 2021 | -54.61% |
| Q2 2021 | 20.76% |
| Q1 2021 | -64.72% |
| Q4 2020 | -126.98% |
| Q3 2020 | 22.26% |
| Q2 2020 | 12.56% |
| Q1 2020 | 0.00% |